药物检查计划的见解:练习公共卫生,同时适应当地药物使用者的需求
Jeff Ondocsin1,2, Daniel Ciccarone2, Lissa Moran1
1Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA 94143, USA.
概括
街头毒品检查计划通过识别物质成分,防止过量死亡,提供重要的危害降低. 实施和维持这些服务需要解决药物市场的不稳定性,并将它们与其他健康计划相结合.
科学领域:
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
- 社区健康 社区健康
背景情况:
- 2021年的过量危机,加剧了COVID-19大流行压力和芬太尼的扩散,需要创新的减少危害服务.
- 基于街头的药物检查计划提供了有关物质成分的关键信息,避免意外过量服用,并将个人与治疗联系起来.
- 现有的减少危害的努力需要加强,以有效地应对不断升级的过量疫情.
研究的目的:
- 为了捕捉服务提供商对社区药物检查计划最佳实践的观点.
- 确定实施和维持药物检查倡议的促进者和障碍者.
- 探索药物检查与其他健康促进和减少伤害服务的整合潜力.
主要方法:
- 在2022年6月至11月期间,与减少危害服务提供商进行了11次深入采访.
- 使用Zoom进行长达45-60分钟的远程采访,记录和转录所有会议.
- 采用受过训练的分析师团队的专题分析来解释采访数据.
主要成果:
- 关键主题包括药物市场的不稳定性和危险的药物供应.
- 成功实施需要动态的服务提供,适应社区需求.
- 可持续发展的基本要素包括全面培训,能力建设和与现有服务的整合.
结论:
- 药物检查计划在不断发展的药物市场中,为减少过量死亡提供了重大机会.
- 由于政策背景和计划悖论,有效实施和长期可持续性仍然面临挑战.
- 将药物检查服务整合到更广泛的降低危害框架中,对于最大限度地提高影响力和可扩展性至关重要.
相关概念视频
Community Based Intervention
66
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
66
Analysis of Population Pharmacokinetic Data
306
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
306
Bootstrapping
636
The term "bootstrap" originated in the 19th century as a metaphor for self-improvement or achieving something independently, without external assistance. This concept extends to statistical bootstrapping, a self-contained method for estimating population parameters through resampling, even though it can be computationally intensive. Developed by the American statistician Dr. Bradley Efron in 1979, bootstrapping provides a robust way to perform inference when the original sample size is...
636
Drug Control Governance: Regulatory Bodies and Their Impact
195
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
195
Drug Discovery: Overview
8.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.1K
Pharmacovigilance
914
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
914


